Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse APC ELISA Kit (AC2518)
Cat.#: ASET-1107
Specifications
Description Mouse APC ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse APC concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.13 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1630 Monkey Prealbumin ELISA Kit (AC3041) Quantitative inquiry ASET-1323 Rat Glutamine Synthetase ELISA Kit (AC2734) Quantitative inquiry ASET-1108 Human Wnt5a ELISA Kit (AC2519) Quantitative inquiry ASET-2453 Human CLSTN1 ELISA Kit (AC3864) Quantitative inquiry ASET-2488 Mouse Progranulin ELISA Kit (AC3899) Quantitative inquiry ASET-2065 Human FLJ39155 ELISA Kit (AC3476) Quantitative inquiry ASET-1731 Human CD45 ELISA Kit (AC3142) Quantitative inquiry ASET-1218 Rat GAPDH ELISA Kit (AC2629) Quantitative inquiry ASET-1497 Human Hyaluronan Synthase 2 ELISA Kit (AC2908) Quantitative inquiry ASET-1425 Mouse Synaptophysin ELISA Kit (AC2836) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket